Clinical Trials

The discovery of GCC expression as a unique biomarker for detecting metastatic colorectal cancer has led to the development of the GCC Cancer Vaccine and GCC CAR-T cell therapeutics.

Click below to learn more to read about the clinical trials for these potential breakthrough therapies.

 

GCC Cancer VaccineGCC CAR-T
FDA phase I clinical trial complete; currently preparing for FDA phase IIa clinical trial Preclinical trials completed; preparations for FDA phase I clinical trial are underway
Preclinical Study
Phase I Trial
Phase II Trial Design
Preclinical Study
Phase I Trial